|
Commitments and Contingencies (Details) (USD $)
|
0 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
|
Oct. 30, 2013
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Licenses | ||||
| Value of temporary equity purchased by licensee | 120,562,138us-gaap_TemporaryEquityCarryingAmountAttributableToParent | $ 58,957,834us-gaap_TemporaryEquityCarryingAmountAttributableToParent | ||
| Reverse stock split ratio | 0.1613us-gaap_StockholdersEquityNoteStockSplitConversionRatio1 | |||
| Series C convertible preferred stock | ||||
| Licenses | ||||
| Value of temporary equity purchased by licensee |
59,935,986us-gaap_TemporaryEquityCarryingAmountAttributableToParent / us-gaap_StatementClassOfStockAxis = trvn_RedeemableConvertibleSeriesCPreferredStockMember |
|||
| Actavis plc (formerly Forest Laboratories Holdings Limited) | Series C convertible preferred stock | ||||
| Licenses | ||||
| Value of temporary equity purchased by licensee |
30,000,000us-gaap_TemporaryEquityCarryingAmountAttributableToParent / us-gaap_CounterpartyNameAxis = trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember / us-gaap_StatementClassOfStockAxis = trvn_RedeemableConvertibleSeriesCPreferredStockMember |
|||
| Option agreement and a license agreement | Minimum | ||||
| Licenses | ||||
| Tiered royalties that could be received, as a percentage of net sales of licensed products |
10.00%trvn_CollaborativeArrangementTieredRoyaltyRevenueThatCouldBeReceivedAsAPercentageOfNetSalesOfLicensedProducts / us-gaap_RangeAxis = us-gaap_MinimumMember / us-gaap_TypeOfArrangementAxis = us-gaap_CollaborativeArrangementProductAgreementMember |
|||
| Option agreement and a license agreement | Maximum | ||||
| Licenses | ||||
| Tiered royalties that could be received, as a percentage of net sales of licensed products |
20.00%trvn_CollaborativeArrangementTieredRoyaltyRevenueThatCouldBeReceivedAsAPercentageOfNetSalesOfLicensedProducts / us-gaap_RangeAxis = us-gaap_MaximumMember / us-gaap_TypeOfArrangementAxis = us-gaap_CollaborativeArrangementProductAgreementMember |
|||
| Option agreement and a license agreement | Actavis plc (formerly Forest Laboratories Holdings Limited) | ||||
| Licenses | ||||
| Consideration received upon the grant of the option |
0trvn_CollaborativeArrangementConsiderationReceivedUponGrantOfOption / us-gaap_CounterpartyNameAxis = trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember / us-gaap_TypeOfArrangementAxis = us-gaap_CollaborativeArrangementProductAgreementMember |
|||
| Aggregate potential consideration |
365,000,000trvn_CollaborativeArrangementMaximumPotentialConsideration / us-gaap_CounterpartyNameAxis = trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember / us-gaap_TypeOfArrangementAxis = us-gaap_CollaborativeArrangementProductAgreementMember |
|||
| Option exercise fee |
65,000,000trvn_CollaborativeArrangementUpfrontOptionExerciseFee / us-gaap_CounterpartyNameAxis = trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember / us-gaap_TypeOfArrangementAxis = us-gaap_CollaborativeArrangementProductAgreementMember |
|||
| Term of royalty on sales from the first commercial sale of product | 10 years | |||
| Option agreement and a license agreement | Actavis plc (formerly Forest Laboratories Holdings Limited) | Series C convertible preferred stock | ||||
| Licenses | ||||
| Value of temporary equity allocated to the option agreement |
0trvn_TemporaryEquityValueAllocatedToTheOptionAgreement / us-gaap_CounterpartyNameAxis = trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember / us-gaap_StatementClassOfStockAxis = trvn_RedeemableConvertibleSeriesCPreferredStockMember / us-gaap_TypeOfArrangementAxis = us-gaap_CollaborativeArrangementProductAgreementMember |
|||
| Reverse stock split ratio |
0.1613us-gaap_StockholdersEquityNoteStockSplitConversionRatio1 / us-gaap_CounterpartyNameAxis = trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember / us-gaap_StatementClassOfStockAxis = trvn_RedeemableConvertibleSeriesCPreferredStockMember / us-gaap_TypeOfArrangementAxis = us-gaap_CollaborativeArrangementProductAgreementMember |
|||
| X | ||||||||||
|
- Definition
Represents the consideration received by the reporting entity upon grant of option to the counterparty under the agreement. No definition available.
|
| X | ||||||||||
|
- Definition
Describes the maximum potential amount of consideration, undiscounted, which could be received under the agreement. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the term of royalty on sales receivable by the entity starting from the first commercial sale effected of the licensed product under the agreement. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the tiered royalty that could be received, expressed as a percentage of net sales of licensed products. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the upfront option exercise fee included in the potential consideration. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the fair value of the temporary equity allocated to the option agreement. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|